HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Determination of plasma warfarin concentrations in Korean patients and its potential for clinical application.

AbstractBACKGROUND:
Warfarin is a widely used oral anticoagulant with broad within- and between-individual dose requirements. Warfarin concentrations can be monitored by assessing its pharmacologic effects on International Normalized Ratio (INR). However, this approach has not been applied in the routine clinical management of patients receiving warfarin therapy. We performed a plasma warfarin assay using high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) to determine if such an assay can be utilized in routine clinical practice.
METHODS:
We included a total of 105 patients with atrial fibrillation, and who were receiving warfarin for more than 1 yr. The plasma concentrations of total warfarin and 7-hydroxywarfarin were determined by HPLC-MS/MS (Waters, UK). We assessed the association between warfarin dose, concentration, and INR as well as the effects of these factors on warfarin concentrations.
RESULTS:
The mean maintenance dose of warfarin in 105 patients was 4.1 +/-1.3 mg/day (range, 1.7-8.0 mg/day) and their mean plasma warfarin concentration was 1.3+/-0.5 mg/L. We defined a concentration range of 0.6-2.6 mg/L (corresponding to the 2.5th to 97.5th percentile range of the Plasma warfarin levels in the 74 patients showing INR within target range) as the therapeutic range for warfarin. The correlation of warfarin dose with warfarin concentration (r(2)=0.259, P<0.001) was higher than that with INR (r(2)=0.029, P=0.072).
CONCLUSIONS:
There was a significant correlation between warfarin dose and plasma warfarin concentrations in Korean patients with atrial fibrillation. Hence, plasma warfarin monitoring can help determine dose adjustments and improve our understanding of individual patient response to warfarin treatment.
AuthorsMin-Jung Kwon, Hee-Jin Kim, Jong-Won Kim, Kyung-Hoon Lee, Kie-Ho Sohn, Hyun-Jung Cho, Young-Keun On, June-Soo Kim, Soo-Youn Lee
JournalThe Korean journal of laboratory medicine (Korean J Lab Med) Vol. 29 Issue 6 Pg. 515-23 (Dec 2009) ISSN: 1598-6535 [Print] Korea (South)
PMID20046082 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticoagulants
  • Warfarin
  • 7-hydroxywarfarin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants (blood, therapeutic use)
  • Asian People
  • Atrial Fibrillation (drug therapy)
  • Chromatography, High Pressure Liquid
  • Female
  • Humans
  • Male
  • Middle Aged
  • Republic of Korea
  • Tandem Mass Spectrometry
  • Warfarin (analogs & derivatives, blood, metabolism, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: